Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Parenthetical)

v3.26.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Investments in marketable securities, amortized cost $ 29,780 $ 3,953
Accounts receivable allowance 5 3
Tax credits receivable allowance $ 435 $ 423
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 190,000,000 190,000,000
Common stock, shares issued 62,684,804 55,282,150
Common stock, shares outstanding 62,259,654 54,857,000
Treasury Stock, Common [Member]    
Treasury stock, shares 425,150 425,150
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 6,000 6,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 0 0
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series C Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 50,000 50,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series D Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 300,000 300,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0